Wensha Yang's lab focuses on improving radiation therapy for liver tumors by combining advanced imaging techniques with treatment planning strategies. They aim to minimize damage to healthy liver tissue while effectively targeting tumors, thereby reducing complications such as radiation-induced liver disease. Their innovative approach includes a novel MR imaging technique and optimizing treatment plans to enhance patient outcomes.

Dr. Lei Xing's lab at Stanford University focuses on improving radiation therapy through advanced quality assurance tools that utilize artificial intelligence (AI). The lab develops deep learning models that enhance the accuracy and reliability of treatment plans in radiation oncology, ensuring better patient care. Their work aims to streamline the workflow in radiation therapy and make treatment safer and more efficient for patients.

Dr. Yuting Lin's research focuses on advancing radiation therapy techniques to improve cancer treatment outcomes. Her team is developing a new form of radiation therapy called proton minibeam radiotherapy (pMBRT), which aims to minimize damage to healthy tissues while effectively targeting tumors. Their work includes designing innovative treatment plans and prototypes to facilitate clinical testing of these groundbreaking therapies.

Dr. Frank Pajonk's lab at UCLA focuses on improving radiation therapy for patients with glioblastoma, a type of brain cancer. The research targets the unique properties of cancer stem cells that make tumors resistant to treatment, specifically looking for ways to promote the differentiation of these cells into non-cancerous types. By developing new compounds that can cross the blood-brain barrier, the lab aims to enhance the effectiveness of radiotherapy and ultimately improve patient outcomes.

Dr. Jianghong Rao's lab at Stanford University focuses on improving the effectiveness of radiation therapy for cancer patients, particularly those with prostate cancer. The lab investigates how to target cancer cells while minimizing damage to healthy tissues by using novel prodrugs and nanotechnology. Their approach seeks to enhance the treatment's efficacy by delivering drugs specifically to dying cancer cells and developing imaging-guided strategies for better treatment outcomes.

Professor Zibo Li's lab focuses on developing new techniques for labeling biomolecules with fluorine-18, a radioactive isotope used in medical imaging. The research aims to create efficient tools for producing radiolabeled agents that can improve the visualization of drug distribution in the brain and enhance medical imaging technologies. This work could significantly impact the fields of drug discovery and cancer imaging.

Dr. Sangeeta Ray's lab focuses on cancer therapies, particularly using targeted radiopharmaceuticals to improve treatment outcomes for prostate and renal cancers. By studying how glutamine metabolism influences cancer cell survival and response to radiation, the lab aims to develop innovative therapies that could enhance the effectiveness of existing treatments. Their work is crucial in understanding how to overcome resistance to radiation therapy in these prevalent cancers.

Dr. Arjun Raj's lab focuses on understanding how the intestinal epithelium, which lines the gut, organizes itself at a cellular level. By studying the interactions between cells using advanced technologies, the lab aims to uncover the principles of self-organization and regeneration. This research has important implications for improving tissue repair in diseases affecting the gut.

Dr. David Raleigh's lab at UCSF focuses on understanding and treating meningiomas, a type of brain tumor. The lab studies the genetic mechanisms that cause these tumors and aims to develop better treatments using innovative models. By using human samples and advanced techniques like organoids and CRISPR, they hope to improve outcomes for patients with meningiomas.

The lab of Dr. Nirmala Ramanujam at Duke University focuses on developing innovative imaging technologies to study cellular metabolism and its relation to cancer therapy. Their flagship project is the CapCell Scope, which allows researchers to non-invasively observe metabolic changes and vascular characteristics in tissues. This research aims to enhance our understanding of how tumors respond to treatments, potentially leading to personalized cancer therapies.

Dr. Amanda E. Randles' research lab at Duke University focuses on creating advanced models of the cardiovascular system that can predict how individual patients will respond to various treatments over extended periods of time. By integrating machine learning with physics-based simulations, the lab aims to utilize real-time data from wearable sensors to enhance personalized medicine for cardiovascular diseases. Their innovative approach seeks to improve monitoring and treatment planning for patients, moving beyond short-term simulations to provide long-term, individualized hemodynamic insights.

Dr. Ravinder Reddy's lab at the University of Pennsylvania focuses on understanding muscle metabolism and the role of NAD+ in human health. The lab is pioneering non-invasive imaging techniques to study how muscles generate energy, especially as we age. They aim to develop better methods for measuring important metabolites like NAD+, which could lead to new treatments for various diseases related to muscle function and metabolism.

Dr. Bo Wang's lab at Stanford University focuses on understanding the fundamental principles behind the ability of certain animals to regenerate body parts. They study various species, from planarians to flatworms, using advanced techniques to explore how regeneration works at the cellular level and how this knowledge can be applied to improve regenerative medicine for humans. By integrating genetics, live imaging, and mathematical modeling, the lab aims to uncover key mechanisms that can enhance tissue repair and regeneration.

Dr. Michael Regnier's lab at the University of Washington focuses on studying myosin, a key protein in muscle contraction, to understand how genetic mutations affect heart health. By using advanced computer simulations and experimental models, the lab examines the structural and functional impact of specific protein variants associated with heart diseases. Their work combines cutting-edge techniques like molecular dynamics and high-resolution imaging, aiming to enhance understanding of cardiac conditions at the cellular level.

Dr. David A Reiter's lab focuses on improving the treatment of diabetic foot ulcers by using advanced imaging and blood analysis techniques. The lab's research aims to identify early markers of wound healing to prevent complications such as infections and amputations in diabetic patients. By exploring the relationship between blood flow, metabolism, and inflammatory responses, the lab seeks to develop innovative diagnostic tools and treatment strategies for better patient outcomes.

Dr. Rebecca R. Richards-Kortum's lab focuses on developing innovative diagnostic tools to improve healthcare accessibility, especially in resource-limited settings. They create advanced imaging technologies that enable quick and accurate disease diagnosis, aiming to enhance surgical outcomes for cancer patients and provide effective screening for conditions like esophageal cancer and sickle cell disease. Their work merges biomedical engineering, optics, and artificial intelligence to revolutionize how pathologies are diagnosed and managed.

Dr. Rahim R Rizi's lab focuses on advancing imaging techniques to evaluate lung health and improve treatments for lung diseases. The research aims to make lung transplants safer and more effective and to develop non-invasive imaging methods that assess lung function in real time, even in patients who normally can't perform lung function tests. They also explore treatments for conditions like emphysema, aiming to enhance patient outcomes.

Dr. Justin Merritt's lab at Oregon Health & Science University explores the complex interactions of proteins in the bacteria Streptococcus mutans, which is closely linked to tooth decay. The research focuses on a unique protein complex called the RNA degradosome, which helps these bacteria manage gene regulation in response to their environment. By studying how different proteins work together within this complex, the lab aims to identify new therapeutic targets to reduce S. mutans levels and combat dental caries.

Dr. Xiaohu Gao's lab at the University of Washington focuses on developing innovative methods for delivering RNA-based therapies, particularly in cancer treatment. By utilizing advanced nanotechnology, the lab is creating unique RNA nanocarriers that can effectively deliver small interfering RNA (siRNA) while overcoming challenges associated with traditional delivery methods. The research aims to enhance the efficiency and specificity of siRNA delivery for therapeutic applications.

Dr. Mario Ignacio Romero-Ortega's lab at the University of Arizona focuses on developing advanced interfaces for improving sensory and motor control in prosthetic limbs for amputees. Their research aims to create tiny, highly selective electrode arrays that can better connect to the nerves in residual limbs, allowing for more intuitive control and natural sensations from robotic prosthetics. This work could significantly enhance the quality of life for people using prosthetic limbs.